Skip to main content

Fayez Sarofim & Co

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 937729 Houston, TX

Position in REGN

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,533,908
-$366,786 QoQ
Shares Held
2,460
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#567
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fayez Sarofim & Co holds $7,172,383 across 4 Biotechnology names. REGN ranks #2 (21.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
2,460 $1,533,908

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,533,908 2,460
2026-03-31 $1,900,694 2,460
2025-12-31 $1,910,378 2,475
2025-09-30 $1,433,788 2,550
2025-06-30 $1,357,125 2,585
2025-03-31 $1,648,998 2,600
2024-12-31 $1,905,482 2,675
2024-09-30 $2,812,067 2,675
2024-06-30 $2,811,505 2,675
2024-03-31 $2,574,660 2,675
2023-12-31 $2,414,419 2,749
2023-09-30 $2,201,418 2,675
2023-06-30 $1,922,094 2,675
2023-03-31 $2,197,967 2,675
2022-12-31 $1,911,948 2,650
2022-09-30 $1,618,844 2,350
2022-06-30 $1,389,155 2,350
2022-03-31 $1,606,366 2,300
2021-12-31 $1,136,736 1,800
2021-09-30 $302,590 500
2021-06-30 $279,270 500
2021-03-31 $378,512 800
2020-12-31 $571,519 1,183
2020-09-30 $592,247 1,058
2020-06-30 $659,821 1,058
2020-03-31 $516,610 1,058